Testing effectiveness (Phase 2)Study completedNCT00616161
What this trial is testing
A Phase II Trial to Assess Hemodynamic Effects of Istaroxime in Pts With Worsening HF and Reduced LV Systolic Function
Who this might be right for
Heart Failure
sigma-tau i.f.r. S.p.A. 120